This week, the industry saw rapid technological integration on the factory floor, a strategic shift toward globalized development networks, and leadership upheaval at the FDA. The pharmaceutical ...

Valerie Bandy, Tecsys, discusses how manufacturers are adopting data-driven supply chain strategies to reduce drug shortages, ...

There is a significant reliance on manual workarounds. When a drug becomes unavailable, pharmacy teams may need to compound ...

Regionalized early development affects clinical supply, analytical transfer, comparability strategies, and regulatory ...

European biopharma companies are looking beyond GLP-1s. Obesity is a major public health threat and is associated with an increased risk of obesity-related complications and mortality. It has proved a ...

FDA leadership churn and reported political interference eroded internal cohesion, contributing to resignations of senior career officials and a climate of dysfunction impacting scientific review ...

This article evaluates a structured, risk-based framework for the development, execution, and life cycle governance of master production and control records and batch production and control records ...

AI is transforming drug discovery and manufacturing, with agentic systems and digital twins enhancing efficiency and decision-making. Geopolitical uncertainties are driving supply chain ...

Reports indicate White House approval to remove Marty Makary, reflecting internal discomfort with political fallout from provocative regulatory shifts and intensifying congressional and ...

Dirk Schuster is sales director Pharma at groninger & co. GmbH as well as a member of the company’s management board. He is responsible for global sales activities in the pharmaceutical sector, with a ...

More than $21 billion of Lilly’s domestic manufacturing commitments this decade have been directed to Indiana.¹ The Lebanon ...

As a critical raw material for our manufacturing operations, media and buffers sit at the heart of the supply chain. On the ...